Perry Xu

Perry Xu

Auto-generated profile, based on publicly available information

Perry Xu

Department of Urology, Northwestern University, Chicago, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Urologic Clinics of North America
Verified
Journal Article
Closed access
PXPerry J. Xu
Perry J. Xu
AKAmy Krambeck
Amy Krambeck

Verified
Journal Article
Open access
PDF file
PXPerry Xu
Perry Xu
AKAmy Krambeck
Amy Krambeck
In this study, AEEP (anatomical enucleation of the prostate) with a thulium laser was performed in 115 men at a single institution between January 2019 and March 2022 for surgical treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Verified
Journal Article
Open access
PDF file
JPJack Thomas Peterson
Jack Thomas Peterson
JGJenny N. Guo
Jenny N. Guo
APAmir Shahreza Patel
Amir Shahreza Patel
NKNabila Khondakar
Nabila Khondakar
PXPerry Xu
Perry Xu
AKAmy Krambeck
Amy Krambeck
Background/Objectives: Obesity has been associated with the development and severity of benign prostatic hyperplasia (BPH), yet its influence on outcomes following definitive surgical management, like holmium laser enucleation of the prostate (HoLEP), remains unclear. Furthermore, gradation of body mass index (BMI) severity has yet to discern personalized outcome stratification. We evaluated BMI’s influence on perioperative, immediate, short-term follow-up, and patient-reported outcomes for HoLEP patients. Methods: We performed a retrospective review of a prospectively maintained database of patients undergoing HoLEP for BPH at a single institution between January 2021 and August 2025. Outcomes included operative characteristics, post-operative complications, and validated symptom score changes. Analyses treated BMI as both a continuous and categorical variable. Multivariable linear and logistic regression models adjusted for common colinear confounders. Results: Among 1445 patients, BMI was not associated with most immediate, three-month, or patient-reported outcomes. Surgical complications were low across all BMI categories, and post-operative reported outcomes indicating high success rate for HoLEP. Higher BMI correlated with a modest increase in enucleation time (β = 0.197; p = 0.0132), increased odds of dysuria (OR = 1.084; p < 0.001), and change in American Urological Association Symptom Score (β = 0.211; p = 0.0334). All other operative metrics, complication rates, continence outcomes, and symptom scores (17 other total) were independent of BMI. Conclusions: After adjustment for relevant confounders, BMI does not meaningfully predict surgical safety, functional recovery, or patient-reported benefit following HoLEP. BMI alone should not influence candidacy or risk stratification for HoLEP in patients with BPH, instead favoring personalized, risk-stratified approaches.


31 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
APAmir Patel
Amir Patel
PXPerry Xu
Perry Xu
ARAriel Roane
Ariel Roane
CGCora Gibbs
Cora Gibbs
DMDanit Mechlovich
Danit Mechlovich
AKAmy Krambeck
Amy Krambeck
Purpose The goal of our study is to identify the incidence of ureteral strictures after ureteroscopic laser lithotripsy (ULL) with the TFL compared to the Ho:YAG laser. Methods In a nationally representative de-identified aggregate electronic health record database (Truveta Inc.), we studied subjects ≥ 18 years of age who underwent ULL between 2020 and 2024 with at least 3 months of follow up. Subjects were split into a Ho:YAG and TFL cohort. The incidence of ureteral strictures at 6 months was the primary outcome. Results There were 5,922 subjects in the Ho:YAG cohort and 541 in the TFL cohort. 93.2% of the Ho:YAG cohort underwent ULL with a Moses™ fiber. TFL use approximately doubled the rate of stricture formation compared to the Ho:YAG laser at 6 months (5.7% vs 2.8% (p = < 0.001)). Multivariate analysis controlling for relevant variables found that TFL use had an adjusted relative risk of 2.09 (95% CI 1.41, 3.01) for ureteral stricture formation. When a sub-group of Moses Ho:YAG subjects were evaluated against TFL, the adjusted relative risk remained significant at 2.14 (95% CI 1.45, 3.07). Conclusion This large database analysis found approximately double the rate of ureteral strictures with the TFL compared to the Ho:YAG laser on multivariate analysis. Similar findings are seen in a subgroup analysis comparing Moses Ho:YAG to TFL, with the assumption that this compares lasers with similar power and settings.

18 August 2025 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
CWClarissa Wong
Clarissa Wong
PXPerry Xu
Perry Xu
MGMeera Ganesh
Meera Ganesh
NKNabila Reem Khondakar
Nabila Reem Khondakar
LGLuis Gago
Luis Gago
AKAmy Krambeck
Amy Krambeck